US EditionTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- On May 21, 2025, TransMedics Group, Inc. Granted stock options and restricted stock units to 15 new employees as an inducement to join the company.
- The grants were made to fulfill employment-related inducements and received approval from the company’s Compensation Committee in compliance with applicable Nasdaq regulations.
- TransMedics granted options to purchase 9,940 shares at $121.31 per share and 6,670 restricted stock units, with vesting schedules tied to continued service over four years and ten-year option terms.
- The exercise price matched the closing Nasdaq price on May 21, 2025, and vesting stipulates 25% after one year with monthly increments thereafter, reflecting standard employee equity incentives.
- These grants support TransMedics’ efforts to attract skilled employees as the company continues to advance innovative therapies for patients suffering from advanced diseases affecting the heart, lungs, and liver.
Insights by Ground AI
Does this summary seem wrong?
23 Articles
23 Articles
All
Left
2
Center
7
Right
2
Chatham Star Tribune+22 Reposted by 22other sources
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., May 27, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on May 21, 2025, TransMedics…
Coverage Details
Total News Sources23
Leaning Left2Leaning Right2Center7Last UpdatedBias Distribution64% Center
Bias Distribution
- 64% of the sources are Center
64% Center
L 18%
C 64%
R 18%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
